medigraphic.com

2005, Number 3

<< Back Next >>

Rev Med Hosp Gen Mex 2005; 68 (3)

Frequency the central nervous system malformations congenital in newborn. Experience 5 years in the Hospital General de México

Islas DLP, Solís HH, Galicia FL, Monzoy VMA

Language: Spanish
References: 16
Page: 131-135
PDF size: 67.07 Kb.


ABSTRACT

Objective: To know the frequency and prevalence for sex and gestation age of congenital malformations of Nervous System in recently born alive in Neonatology. Material and methods: To revise of clinics expedients of recently born alive during the period 2000 at 2004, with congenital defects of nervous system. Results: During this period of five years, 76 cases were captured of recently born with congenital defects. The most frequently of congenital hydrocephaly in 44.7% (n = 34), the mielomeningocele in 30.2% (n = 16). To predominate the masculine sex with a relation masculine/feminine of 0.5. The maternal age is the 16 to 20 years in 42.1% (n = 32). Alone the 39.4% (n = 30) to turn a prenatal control. Conclusions: To observe a increase of the congenital malformations of the nervous system, with the prevalence of 2.4 for 1000 recently born, prevailing in the masculine sex; being the congenital hydrocephaly the most frequent; consecutive the defects of the tube neural.


REFERENCES

  1. Ortiz AMR, Flores FG, Cardiel MLE, Luna RC. Frecuencia de malformaciones congénitas en el área de neonatología del Hospital General de México. Rev Mex Pediat 2003; 70 (3): 128-131.

  2. Cloherty JP, Stark AR. Manual de cuidados neonatales. Philadelphia: Masson, 2001; 599-608.

  3. Volpe J. Neurología del recién nacido. Philadelphia: Mosby, 2001; 3-40

  4. Pérez-Molina JJ, Ochoa PC, Alfaro-Alfaro N, Defectos del tubo neural altos y bajos prevalencia y asociación con enfermedades y medicamentos. Rev Mex Ginecol Obstet 2002; 70 (9): 443-450.

  5. Pérez-Molina JJ, Alfaro-Alfaro N. Defectos del cierre del tubo neural: Prevalencia y búsqueda de asociación con algunos factores de riesgo durante el primer trimestre del embarazo. Bol Med Hosp Inf Mex 1998; 55: 435-442.

  6. Kaufman BA, Neural tube defects. Pediat Clin N Am 2004; 51: 389-319.

  7. Kozer E, Shekoufeh N, Costei A. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: A meta-analysis. Am J Obstet Ginecol 2002; 187 (6): 10-22.

  8. Slattery ML, Janerich DT. The epidemiology of neural tube defects: a review of dietary intake and related factors as etiologic agents. Am J Epidemiol 1991; 133: 526-540.

  9. Vieira AR, Birth order and neural tube defects: A reappraisal. J Neurol Sci 2004; 217: 65-72.

  10. Garabedian BH, Fraser FC. Upper and lower neural tube defects: an alternate hypothesis. J Med Genet 1993; 30: 849-851.

  11. Leeker M, Beinder E. Twin pregnancies discordant for anencephaly: management, pregnancy outcome and review of literature. Eur J Obstet Ginecol 2004; 114: 15-18.

  12. Sarnat HB. Molecular genetic classification of central nervous system malformations. J Child Nurol 2000; 15 (10) 675-687.

  13. Canick JA, Kellner LH, Allan TMS. Prenatal screening for open neural tube defects. Clin Lab Med 2003; 23: 385-394.

  14. Graves CJ, Miller KE. Maternal serum triple analyte screening in pregnancy. Am Fam Phys 2002; 65 (5): 915-920.

  15. Rothenberg SP, Costa MP. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural tube defect. N Engl J Med 2004; 350: 134-142.

  16. Tulipan N. Intrauterine myelomeningocele repair. Clin Perinatol 2003; 30: 521-350.




2020     |     www.medigraphic.com